Clene Nanomedicine


Clene is a clinical-stage biopharmaceutical company focused on the development of unique therapeutics for neurodegenerative diseases.

Industries

Employees

51-200

Links


Org chart

Rob Etherington
President & CEO
Collapse
Mark Mortenson
Chief Science Officer
Michael Hotchkin
Chief Development Officer
Jerry Miraglia
General Counsel & Corporate Secretary
Adam Dorfman
Vp, Quality & Technical Operations
Jennifer Hotchkin
Commercial Planning And Strategy, Executive Director
Marjan Sepassi
Vice President Medical Affairs

Board & advisors

Alison Mosca
Board Member
John Stevens
Board Member
Jonathon Gay
Board Member
Reed Wilcox
Board Member


Offices